The increasing incidence and prevalence of female multiple sclerosis-A critical analysis of potential environmental factors

Autoimmunity Reviews

Volumn 10, Issue 8, 2011, Pages 495-502

  Sellner, Johann ^a,b   Kraus, Jörg ^b   Awad, Amer ^c   Milo, Ron ^d   Hemmer, Bernhard ^a   Stüve, Olaf ^e,f  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

^c Baton Rouge General   (United States)

^d BARZILAI MEDICAL CENTER   (Israel)

^e VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Environmental trigger; Female preponderance; Multiple sclerosis; Pathogenesis; Sex ratio

Indexed keywords

AUTOANTIGEN; VITAMIN D;

AUTOIMMUNE DISEASE; B LYMPHOCYTE ACTIVATION; CELLULAR IMMUNITY; CIGARETTE SMOKING; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; HEALTH CARE ACCESS; HUMAN; INCIDENCE; INFLAMMATION; LIFESTYLE; LYMPHOCYTE DIFFERENTIATION; MATERNAL AGE; MIGRATION; MULTIPLE SCLEROSIS; OBESITY; ORAL CONTRACEPTION; PATIENT ASSESSMENT; PREVALENCE; REVIEW; SEX RATIO; SUN EXPOSURE; T LYMPHOCYTE; VITAMIN D DEFICIENCY; WOMEN'S HEALTH;

AUTOANTIBODIES; AUTOANTIGENS; B-LYMPHOCYTES; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNOMODULATION; INCIDENCE; MALE; MULTIPLE SCLEROSIS; PREVALENCE; SEX FACTORS; T-LYMPHOCYTES; VITAMIN D;

EID: 79957664940     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2011.02.006     Document Type: Review

References (108)

1. Milo R., Kahana E. Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmun Rev 2010, 9:A387-A394.
2. Ebers G.C., Bulman D.E., Sadovnick A.D., Paty D.W., Warren S., Hader W., et al. A population-based study of multiple sclerosis in twins. N Engl J Med 1986, 315:1638-1642.
3. Nielsen N.M., Westergaard T., Rostgaard K., Frisch M., Hjalgrim H., Wohlfahrt J., et al. Familial risk of multiple sclerosis: a nationwide cohort study. Am J Epidemiol 2005, 162:774-778.
4. Ramagopalan S.V., Maugeri N.J., Handunnetthi L., Lincoln M.R., Orton S.M., Dyment D.A., et al. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1 1501 is regulated by vitamin D. PLoS Genet 2009, 5:e1000369.
5. Rojas O.L., Rojas-Villarraga A., Cruz-Tapias P., Sanchez J.L., Suarez-Escudero J.C., Patarroyo M.A., et al. HLA class II polymorphism in Latin American patients with multiple sclerosis. Autoimmun Rev 2010, 9:407-413.
6. Ascherio A., Munger K.L. Environmental risk factors for multiple sclerosis. Part II: noninfectious factors. Ann Neurol 2007, 61:504-513.
7. Goodin D.S. The causal cascade to multiple sclerosis: a model for MS pathogenesis. PLoS ONE 2009, 4:e4565.
8. Koch-Henriksen N., Sorensen P.S. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 2011, 9:520-532.
9. Stadelmann C., Wegner C., Bruck W. Inflammation, demyelination, and degeneration-recent insights from MS pathology. Biochim Biophys Acta 2010, 1812:275-282.
10. Chao M.J., Herrera B.M., Ramagopalan S.V., Deluca G., Handunetthi L., Orton S.M., et al. Parent-of-origin effects at the major histocompatibility complex in multiple sclerosis. Hum Mol Genet 2010, 19:3679-3689.
11. Chao M.J., Ramagopalan S.V., Herrera B.M., Lincoln M.R., Dyment D.A., Sadovnick A.D., et al. Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex. Hum Mol Genet 2009, 18:261-266.
12. Chao MJ R.S., Herrera B.M., Orton S.M., Handunnetthi L., Lincoln M.R., Dyment D.A., et al. MHC transmission: insights into gender bias in MS susceptibility. Neurology 2011, 76:242-246.
13. Mayr W.T., Pittock S.J., McClelland R.L., Jorgensen N.W., Noseworthy J.H., Rodriguez M. Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000. Neurology 2003, 61:1373-1377.
14. Grytten N., Glad S.B., Aarseth J.H., Nyland H., Midgard R., Myhr K.M. A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway. Neurology 2006, 66:182-186.
15. Gijsbers van Wijk C.M., van Vliet K.P., Kolk A.M. Gender perspectives and quality of care: towards appropriate and adequate health care for women. Soc Sci Med 1996, 43:707-720.
16. Hibbard J.H., Pope C.R. Gender roles, illness orientation and use of medical services. Soc Sci Med 1983, 17:129-137.
17. Green C.A., Pope C.R. Gender, psychosocial factors and the use of medical services: a longitudinal analysis. Soc Sci Med 1999, 48:1363-1372.
18. Hirst C., Ingram G., Pickersgill T., Swingler R., Compston D.A., Robertson N.P. Increasing prevalence and incidence of multiple sclerosis in South East Wales. J Neurol Neurosurg Psychiatry 2009, 80:386-391.
19. Orton S.M., Ramagopalan S.V., Brocklebank D., Herrera B.M., Dyment D.A., Yee I.M., et al. Effect of immigration on multiple sclerosis sex ratio in Canada: the Canadian Collaborative Study. J Neurol Neurosurg Psychiatry 2010, 81:31-36.
20. Glad S.B., Nyland H.I., Aarseth J.H., Riise T., Myhr K.M. Long-term follow-up of benign multiple sclerosis in Hordaland County, Western Norway. Mult Scler 2009, 15:942-950.
21. Hawkins S.A., McDonnell G.V. Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors. J Neurol Neurosurg Psychiatry 1999, 67:148-152.
22. Ladwig K.H., Marten-Mittag B., Formanek B., Dammann G. Gender differences of symptom reporting and medical health care utilization in the German population. Eur J Epidemiol 2000, 16:511-518.
23. Saxena S., Eliahoo J., Majeed A. Socioeconomic and ethnic group differences in self reported health status and use of health services by children and young people in England: cross sectional study. Bmj 2002, 325:520.
24. Simpson S., Pittas F., van der Mei I., Blizzard L., Ponsonby A.L., Taylor B. Trends in the epidemiology of multiple sclerosis in Greater Hobart, Tasmania: 1951 to 2009. J Neurol Neurosurg Psychiatry 2011, 82:180-187.
25. Osoegawa M., Kira J., Fukazawa T., Fujihara K., Kikuchi S., Matsui M., et al. Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30years. Mult Scler 2009, 15:159-173.
26. Krokki O., Bloigu R., Reunanen M., Remes A. Increasing incidence of multiple sclerosis in women in Northern Finland. Mult Scler 2011, 17:133-138.
27. Sellner J., Schirmer L., Hemmer B., Mühlau M. The radiologically isolated syndrome: take action when the unexpected is uncovered?. J Neurol 2010, 257:1602-1611.
28. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.P., Kappos L., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005, 58:840-846.
29. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983, 13:227-231.
30. Orton S.M., Herrera B.M., Yee I.M., Valdar W., Ramagopalan S.V., Sadovnick A.D., et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 2006, 5:932-936.
31. Fox C.M., Bensa S., Bray I., Zajicek J.P. The epidemiology of multiple sclerosis in Devon: a comparison of the new and old classification criteria. J Neurol Neurosurg Psychiatry 2004, 75:56-60.
32. Celius E.G., Smestad C. Change in sex ratio, disease course and age at diagnosis in Oslo MS patients through seven decades. Acta Neurol Scand Suppl 2009, 27-29.
33. Marrie R., Horwitz R., Cutter G., Tyry T., Campagnolo D., Vollmer T. High frequency of adverse health behaviors in multiple sclerosis. Mult Scler 2009, 15:105-113.
34. Pekmezovic T., Drulovic J., Milenkovic M., Jarebinski M., Stojsavljevic N., Mesaros S., et al. Lifestyle factors and multiple sclerosis: a case-control study in Belgrade. Neuroepidemiology 2006, 27:212-216.
35. Dieude P., Boileau C., Allanore Y. Immunogenetics of systemic sclerosis. Autoimmun Rev 2011, 10:282-290.
36. Oliver J.E., Silman A.J. Why are women predisposed to autoimmune rheumatic diseases?. Arthritis Res Ther 2009, 11:252.
37. Wang J., Kay A.B., Fletcher J., Formica M.K., McAlindon T.E. Is lipstick associated with the development of systemic lupus erythematosus (SLE)?. Clin Rheumatol 2008, 27:1183-1187.
38. Ghadirian P., Dadgostar B., Azani R., Maisonneuve P. A case-control study of the association between socio-demographic, lifestyle and medical history factors and multiple sclerosis. Can J Public Health 2001, 92:281-285.
39. Zorzon M., Zivadinov R., Nasuelli D., Dolfini P., Bosco A., Bratina A., et al. Risk factors of multiple sclerosis: a case-control study. Neurol Sci 2003, 24:242-247.
40. Riise T., Nortvedt M.W., Ascherio A. Smoking is a risk factor for multiple sclerosis. Neurology 2003, 61:1122-1124.
41. Hernan M.A., Olek M.J., Ascherio A. Cigarette smoking and incidence of multiple sclerosis. Am J Epidemiol 2001, 154:69-74.
42. Costenbader K.H., Karlson E.W. Cigarette smoking and autoimmune disease: what can we learn from epidemiology?. Lupus 2006, 15:737-745.
43. Emre M., de Decker C. Effects of cigarette smoking on motor functions in patients with multiple sclerosis. Arch Neurol 1992, 49:1243-1247.
44. Di Pauli F., Reindl M., Ehling R., Schautzer F., Gneiss C., Lutterotti A., et al. Smoking is a risk factor for early conversion to clinically definite multiple sclerosis. Mult Scler 2008, 14:1026-1030.
45. Pittas F., Ponsonby A.L., van der Mei I.A., Taylor B.V., Blizzard L., Groom P., et al. Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis. J Neurol 2009, 256:577-585.
46. Maghzi A.H., Ghazavi H., Ahsan M., Etemadifar M., Mousavi S., Khorvash F., et al. Increasing female preponderance of multiple sclerosis in Isfahan, Iran: a population-based study. Mult Scler 2010, 16:359-361.
47. Pi-Sunyer X. The medical risks of obesity. Postgrad Med 2009, 121:21-33.
48. Azarbad L., Gonder-Frederick L. Obesity in women. Psychiatr Clin North Am 2010, 33:423-440.
49. Munger K.L., Chitnis T., Ascherio A. Body size and risk of MS in two cohorts of US women. Neurology 2009, 73:1543-1550.
50. Matarese G., Procaccini C., De Rosa V. The intricate interface between immune and metabolic regulation: a role for leptin in the pathogenesis of multiple sclerosis?. J Leukoc Biol 2008, 84:893-899.
51. Matarese G., Carrieri P.B., La Cava A., Perna F., Sanna V., De Rosa V., et al. Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells. Proc Natl Acad Sci USA 2005, 102:5150-5155.
52. Konradsen S., Ag H., Lindberg F., Hexeberg S., Jorde R. Serum 1, 25-dihydroxy vitamin D is inversely associated with body mass index. Eur J Nutr 2008, 47:87-91.
53. Zandman-Goddard G., Peeva E., Shoenfeld Y. Gender and autoimmunity. Autoimmun Rev 2007, 6:366-372.
54. Villard-Mackintosh L., Vessey M.P. Oral contraceptives and reproductive factors in multiple sclerosis incidence. Contraception 1993, 47:161-168.
55. Thorogood M., Hannaford P.C. The influence of oral contraceptives on the risk of multiple sclerosis. Br J Obstet Gynaecol 1998, 105:1296-1299.
56. Hernan M.A., Hohol M.J., Olek M.J., Spiegelman D., Ascherio A. Oral contraceptives and the incidence of multiple sclerosis. Neurology 2000, 55:848-854.
57. Confavreux C., Hutchinson M., Hours M.M., Cortinovis-Tourniaire P., Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 1998, 339:285-291.
58. Alonso A., Jick S.S., Olek M.J., Ascherio A., Jick H., Hernan M.A. Recent use of oral contraceptives and the risk of multiple sclerosis. Arch Neurol 2005, 62:1362-1365.
59. Nassar A.H., Usta I.M. Advanced maternal age. Part II: long-term consequences. Am J Perinatol 2009, 26:107-112.
60. Ramagopalan S.V., Dyment D.A., Guimond C., Yee I.M., Ebers G.C., Sadovnick A.D. No effect of parental age on risk of multiple sclerosis: a population-based study. Neuroepidemiology 2010, 34:106-109.
61. Staples J., Ponsonby A.L., Lim L. Low maternal exposure to ultraviolet radiation in pregnancy, month of birth, and risk of multiple sclerosis in offspring: longitudinal analysis. Bmj 2010, 340:c1640.
62. Soilu-Hanninen M., Laaksonen M., Laitinen I., Eralinna J.P., Lilius E.M., Mononen I. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis. J Neurol Neurosurg Psychiatry 2008, 79:152-157.
63. Willer C.J., Dyment D.A., Sadovnick A.D., Rothwell P.M., Murray T.J., Ebers G.C. Timing of birth and risk of multiple sclerosis: population based study. BMJ 2005, 330:120.
64. Plum L.A., DeLuca H.F. Vitamin D, disease and therapeutic opportunities. Nat Rev Drug Discov 2010, 9:941-955.
65. Lonergan R., Kinsella K., Fitzpatrick P., Brady J., Murray B., Dunne C., et al. Multiple sclerosis prevalence in Ireland: relationship to vitamin D status and HLA genotype. J Neurol Neurosurg Psychiatry 2011, 82:317-322.
66. Pierrot-Deseilligny C., Souberbielle J.C. Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?. Brain 2010, 133:1869-1888.
67. Shapira Y., Agmon-Levin N., Shoenfeld Y. Defining and analyzing geoepidemiology and human autoimmunity. J Autoimmun 2010, 34:J168-J177.
68. Beretich B.D., Beretich T.M. Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis. Mult Scler 2009, 15:891-898.
69. Vukusic S., Van Bockstael V., Gosselin S., Confavreux C. Regional variations in the prevalence of multiple sclerosis in French farmers. J Neurol Neurosurg Psychiatry 2007, 78:707-709.
70. van der Mei I.A., Ponsonby A.L., Dwyer T., Blizzard L., Simmons R., Taylor B.V., et al. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. Bmj 2003, 327:316.
71. Kampman M.T., Wilsgaard T., Mellgren S.I. Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle. J Neurol 2007, 254:471-477.
72. Lucas R.M., Ponsonby A.L., Dear K., Valery P.C., Pender M.P., Taylor B.V., et al. Sun exposure and vitamin D are independent risk factors for CNS demyelination. Neurology 2011, 76:540-548.
73. Smolders J., Peelen E., Thewissen M., Menheere P., Tervaert J.W., Hupperts R., et al. The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmun Rev 2009, 8:621-626.
74. Pelajo C.F., Lopez-Benitez J.M., Miller L.C. Vitamin D and autoimmune rheumatologic disorders. Autoimmun Rev 2010, 9:507-510.
75. Kragt J., van Amerongen B., Killestein J., Dijkstra C., Uitdehaag B., Polman C., et al. Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women. Mult Scler 2009, 15:9-15.
76. Correale J., Ysrraelit M.C., Gaitan M.I. Gender differences in 1, 25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects. J Immunol 2010, 185:4948-4958.
77. The Australia and New Zealand Multiple Sclerosis Genetics Consortium ANZgene Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 2009, 41:824-828.
78. Sundqvist E., Baarnhielm M., Alfredsson L., Hillert J., Olsson T., Kockum I. Confirmation of association between multiple sclerosis and CYP27B1. Eur J Hum Genet 2010, 18:1349-1352.
79. Fernandes de Abreu D.A., Babron M.C., Rebeix I., Fontenille C., Yaouanq J., Brassat D., et al. Season of birth and not vitamin D receptor promoter polymorphisms is a risk factor for multiple sclerosis. Mult Scler 2009, 15:1146-1152.
80. Tajouri L., Ovcaric M., Curtain R., Johnson M.P., Griffiths L.R., Csurhes P., et al. Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population. J Neurogenet 2005, 19:25-38.
81. Yeo T.W., Maranian M., Singlehurst S., Gray J., Compston A., Sawcer S. Four single nucleotide polymorphisms from the vitamin D receptor gene in UK multiple sclerosis. J Neurol 2004, 251:753-754.
82. Niino M., Kikuchi S., Fukazawa T., Yabe I., Tashiro K. No association of vitamin D-binding protein gene polymorphisms in Japanese patients with MS. J Neuroimmunol 2002, 127:177-179.
83. Niino M., Fukazawa T., Yabe I., Kikuchi S., Sasaki H., Tashiro K. Vitamin D receptor gene polymorphism in multiple sclerosis and the association with HLA class II alleles. J Neurol Sci 2000, 177:65-71.
84. Fukazawa T., Yabe I., Kikuchi S., Sasaki H., Hamada T., Miyasaka K., et al. Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese. J Neurol Sci 1999, 166:47-52.
85. Tang J., Zhou R., Luger D., Zhu W., Silver P.B., Grajewski R.S., et al. Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. J Immunol 2009, 182:4624-4632.
86. Daniel C., Sartory N.A., Zahn N., Radeke H.H., Stein J.M. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther 2008, 324:23-33.
87. Smolders J., Menheere P., Thewissen M., Peelen E., Tervaert J.W., Hupperts R., et al. Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1, 25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis. J Steroid Biochem Mol Biol 2010, 121:243-246.
88. Bruce D., Ooi J.H., Yu S., Cantorna M.T. Vitamin D and host resistance to infection? Putting the cart in front of the horse. Exp Biol Med (Maywood) 2010, 235:921-927.
89. Royal W., Mia Y., Li H., Naunton K. Peripheral blood regulatory T cell measurements correlate with serum vitamin D levels in patients with multiple sclerosis. J Neuroimmunol 2009, 213:135-141.
90. Pender MP. The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis, Neuroscientist. (2011) in press.
91. Sellner J., Cepok S., Kalluri S.R., Nestler A., Kleiter I., Kümpfel T., et al. Aquaporin 4 antibody positive central nervous system autoimmunity and multiple sclerosis are characterized by a distinct profile of antibodies to herpes viruses. Neurochem Int 2010, 57:662-667.
92. Hersey P., Bradley M., Hasic E., Haran G., Edwards A., McCarthy W.H. Immunological effects of solarium exposure. Lancet 1983, 1:545-548.
93. Hersey P., Haran G., Hasic E., Edwards A. Alteration of T cell subsets and induction of suppressor T cell activity in normal subjects after exposure to sunlight. J Immunol 1983, 131:171-174.
94. Lysandropoulos A.P., Jaquiery E., Jilek S., Pantaleo G., Schluep M., Du Pasquier R.A. Vitamin D has a direct immunomodulatory effect on CD8+ T cells of patients with early multiple sclerosis and healthy control subjects. J Neuroimmunol 2011, 233:240-244.
95. Yenamandra S.P., Hellman U., Kempkes B., Darekar S.D., Petermann S., Sculley T., et al. Epstein-Barr virus encoded EBNA-3 binds to vitamin D receptor and blocks activation of its target genes. Cell Mol Life Sci 2010, 67:4249-4256.
96. Holmoy T. Vitamin D status modulates the immune response to Epstein Barr virus: synergistic effect of risk factors in multiple sclerosis. Med Hypotheses 2008, 70:66-69.
97. Sabetta J.R., DePetrillo P., Cipriani R.J., Smardin J., Burns L.A., Landry M.L. Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults. PLoS ONE 2010, 5:e11088.
98. Mowry EM, James JA, Krupp LB, Waubant E. Vitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis, Mult Scler. (2011) in press.
99. Cepok S., Rosche B., Grummel V., Vogel F., Zhou D., Sayn J., et al. Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Brain 2005, 128:1667-1676.
100. Chen S., Sims G.P., Chen X.X., Gu Y.Y., Chen S., Lipsky P.E. Modulatory effects of 1, 25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007, 179:1634-1647.
101. Munger K.L., Levin L.I., Hollis B.W., Howard N.S., Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. Jama 2006, 296:2832-2838.
102. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999, 69:842-856.
103. Handel A.E., Giovannoni G., Ebers G.C., Ramagopalan S.V. Environmental factors and their timing in adult-onset multiple sclerosis. Nat Rev Neurol 2010, 6:156-166.
104. Bentzen J., Flachs E.M., Stenager E., Bronnum-Hansen H., Koch-Henriksen N. Prevalence of multiple sclerosis in Denmark 1950-2005. Mult Scler 2010, 16:520-525.
105. Sahraian M.A., Khorramnia S., Ebrahim M.M., Moinfar Z., Lotfi J., Pakdaman H. Multiple sclerosis in Iran: a demographic study of 8,000 patients and changes over time. Eur Neurol 2010, 64:331-336.
106. Cabre P. Environmental changes and epidemiology of multiple sclerosis in the French West Indies. J Neurol Sci 2009, 286:58-61.
107. Gray O.M., McDonnell G.V., Hawkins S.A. Factors in the rising prevalence of multiple sclerosis in the north-east of Ireland. Mult Scler 2008, 14:880-886.
108. Hader W.J., Yee I.M. Incidence and prevalence of multiple sclerosis in Saskatoon, Saskatchewan. Neurology 2007, 69:1224-1229.